Medical services boosting net profit growth ■ 1HFY3/22 net profit surged 265% yoy to HK$160m and formed 39% of our FY22F forecast. We deem this in line as we expect a stronger 2HFY3/22F. ■ Medical services should drive revenue in FY22-24F, amid organic growth and continuous M&A activities. ■ Reiterate Add. Our TP of HK$16.65 […]

Read more of this post